rs1554517327

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP2PP3

The NM_007175.8(ERLIN2):​c.452C>T​(p.Ala151Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

ERLIN2
NM_007175.8 missense

Scores

6
10
3

Clinical Significance

Uncertain significance criteria provided, single submitter P:1U:1

Conservation

PhyloP100: 7.58
Variant links:
Genes affected
ERLIN2 (HGNC:1356): (ER lipid raft associated 2) This gene encodes a member of the SPFH domain-containing family of lipid raft-associated proteins. The encoded protein is localized to lipid rafts of the endoplasmic reticulum and plays a critical role in inositol 1,4,5-trisphosphate (IP3) signaling by mediating ER-associated degradation of activated IP3 receptors. Mutations in this gene are a cause of spastic paraplegia-18 (SPG18). Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Feb 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), ERLIN2. . Trascript score misZ 3.3024 (greater than threshold 3.09). GenCC has associacion of gene with hereditary spastic paraplegia 18, juvenile primary lateral sclerosis, recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.782

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ERLIN2NM_007175.8 linkuse as main transcriptc.452C>T p.Ala151Val missense_variant 7/12 ENST00000519638.3 NP_009106.1
ERLIN2NM_001362878.2 linkuse as main transcriptc.452C>T p.Ala151Val missense_variant 7/12 NP_001349807.1
ERLIN2XM_047421307.1 linkuse as main transcriptc.452C>T p.Ala151Val missense_variant 8/13 XP_047277263.1
ERLIN2XM_047421308.1 linkuse as main transcriptc.206C>T p.Ala69Val missense_variant 4/9 XP_047277264.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ERLIN2ENST00000519638.3 linkuse as main transcriptc.452C>T p.Ala151Val missense_variant 7/122 NM_007175.8 ENSP00000428112 P1O94905-1
ERLIN2ENST00000521644.5 linkuse as main transcriptc.452C>T p.Ala151Val missense_variant 7/125 ENSP00000429621
ERLIN2ENST00000518526.5 linkuse as main transcriptc.323C>T p.Ala108Val missense_variant 5/83 ENSP00000429229
ERLIN2ENST00000521993.3 linkuse as main transcriptn.381C>T non_coding_transcript_exon_variant 6/73

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Spastic paraplegia 18a, autosomal dominant Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMOct 12, 2023- -
Spastic paraplegia Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpOct 30, 2018Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, this variant is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with an ERLIN2-related disease. This sequence change replaces alanine with valine at codon 151 of the ERLIN2 protein (p.Ala151Val). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and valine. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.63
BayesDel_addAF
Pathogenic
0.20
D
BayesDel_noAF
Uncertain
0.050
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.81
D;D;D;D
Eigen
Uncertain
0.35
Eigen_PC
Uncertain
0.45
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.98
D;.;D;D
M_CAP
Uncertain
0.20
D
MetaRNN
Pathogenic
0.78
D;D;D;D
MetaSVM
Uncertain
0.67
D
MutationAssessor
Uncertain
2.5
.;M;M;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.77
T
PROVEAN
Uncertain
-3.2
D;D;D;D
REVEL
Uncertain
0.59
Sift
Benign
0.063
T;D;D;D
Sift4G
Benign
0.078
T;D;D;D
Polyphen
0.41
.;B;B;.
Vest4
0.41
MutPred
0.59
.;Loss of ubiquitination at K149 (P = 0.1651);Loss of ubiquitination at K149 (P = 0.1651);Loss of ubiquitination at K149 (P = 0.1651);
MVP
0.94
MPC
1.4
ClinPred
0.98
D
GERP RS
5.4
Varity_R
0.51
gMVP
0.77

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1554517327; hg19: chr8-37607104; API